DK0615439T3 - Iburprofen-containing retard drug and its use - Google Patents

Iburprofen-containing retard drug and its use

Info

Publication number
DK0615439T3
DK0615439T3 DK92924545.4T DK92924545T DK0615439T3 DK 0615439 T3 DK0615439 T3 DK 0615439T3 DK 92924545 T DK92924545 T DK 92924545T DK 0615439 T3 DK0615439 T3 DK 0615439T3
Authority
DK
Denmark
Prior art keywords
ibuprofen
iburprofen
racemate
slow
mixture
Prior art date
Application number
DK92924545.4T
Other languages
Danish (da)
Inventor
Jens-Christian Wunderlich
Ursula Schick
Helmut Lukas
Otto Schuster
Original Assignee
Alfatec Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfatec Pharma Gmbh filed Critical Alfatec Pharma Gmbh
Application granted granted Critical
Publication of DK0615439T3 publication Critical patent/DK0615439T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5169—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A medicament contains a slow-release composition of ibuprofen as a racemate, a mixture of racemate with its enantiomers, a pseudoracemate (mixtures of equal parts of S- and R-ibuprofen) or a mixture of different parts of S- and R-ibuprofen in the range between pure S- and ibuprofene as active substance. The slow-release ibuprofen composition constitutes a gelatine-based pharmaceutically applicable nanosol and satisfies the requirements of an efficient thereapy for rheumatism.
DK92924545.4T 1991-12-05 1992-12-04 Iburprofen-containing retard drug and its use DK0615439T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4140172A DE4140172C2 (en) 1991-12-05 1991-12-05 Retard form for a drug containing ibuprofen

Publications (1)

Publication Number Publication Date
DK0615439T3 true DK0615439T3 (en) 1996-01-08

Family

ID=6446382

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92924545.4T DK0615439T3 (en) 1991-12-05 1992-12-04 Iburprofen-containing retard drug and its use

Country Status (8)

Country Link
EP (1) EP0615439B1 (en)
AT (1) ATE129891T1 (en)
AU (1) AU3080092A (en)
DE (2) DE4140172C2 (en)
DK (1) DK0615439T3 (en)
ES (1) ES2082523T3 (en)
GR (1) GR3018931T3 (en)
WO (1) WO1993010760A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4140185C2 (en) * 1991-12-05 1996-02-01 Alfatec Pharma Gmbh Medicament containing a 2-arylpropionic acid derivative in nanosol form and its preparation
DE4140179C2 (en) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Acute form for a drug containing ibuprofen
DE4216756C2 (en) * 1992-05-21 1994-08-25 Pharmatrans Sanaq Ag 2-Arylpropionic acid preparations and process for their preparation
DE4327147C2 (en) * 1993-08-12 1996-12-19 Klinge Co Chem Pharm Fab A pharmaceutical composition which contains a mixture of gelatin of different solubility in addition to the active ingredient
WO2000018374A1 (en) * 1998-10-01 2000-04-06 Elan Pharma International, Ltd. Controlled release nanoparticulate compositions
PT2387391T (en) 2009-07-24 2017-04-20 Mika Pharma Ges Für Die Entw Und Vermarktung Pharmazeutischer Produkte Mbh Method for developing a liquid composition to be applied to the skin as a foam and a composition that can be applied topically

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4571333A (en) * 1983-06-14 1986-02-18 Syntex (U.S.A.) Inc. Controlled release naproxen and naproxen sodium tablets
DE3532562A1 (en) * 1985-09-12 1987-03-12 Dolorgiet Gmbh & Co Kg TRANSDERMALLY RESORBABLE, WATER-BASED PREPARATIONS OF ARYLPROPIONIC ACID DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF
GB8524421D0 (en) * 1985-10-03 1985-11-06 Boots Co Plc Therapeutic agents
JPS62126122A (en) * 1985-11-27 1987-06-08 Showa Shinyaku Kk Production of ibuprofen granule having coated surface
GB8601204D0 (en) * 1986-01-18 1986-02-19 Boots Co Plc Therapeutic agents
US4704436A (en) * 1986-05-02 1987-11-03 Barabas Eugene S Water soluble complex of a poly(vinylpyrrolidone) copolymer and α-methyl-(2-methylpropyl)benzene acetic acid
IT1200178B (en) * 1986-07-23 1989-01-05 Alfa Farmaceutici Spa GALENIC FORMULATIONS WITH SCHEDULED SALE CONTAINING DRUGS WITH ANTI-FLOGISTIC ACTIVITY
DE3669103D1 (en) * 1986-11-14 1990-04-05 Puetter Medice Chem Pharm MEDICINAL PRODUCT CONTAINING IBUPROFEN.
HU205861B (en) * 1986-12-19 1992-07-28 Sandoz Ag Process for producing hydrosole of pharmaceutically effective material
FR2608988B1 (en) * 1986-12-31 1991-01-11 Centre Nat Rech Scient PROCESS FOR THE PREPARATION OF COLLOIDAL DISPERSIBLE SYSTEMS OF A SUBSTANCE, IN THE FORM OF NANOPARTICLES
CA1324083C (en) * 1987-03-09 1993-11-09 Tetsu Miyoshi Pharmaceutical preparations containing non-steroidal anti-inflammatory agents
US4806359A (en) * 1987-04-22 1989-02-21 Mcneilab, Inc. Iburprofen sustained release matrix and process
US4851444A (en) * 1987-07-10 1989-07-25 Analgesic Associates Onset-hastened/enhanced analgesia
US4980375A (en) * 1987-07-10 1990-12-25 Sterling Drug Inc. Onset-hastened/enhanced antipyretic response
US4859704A (en) * 1987-10-15 1989-08-22 Oratech Pharmaceutical Development Corporation Water soluble ibuprofen compositions and methods of making them
US4861797A (en) * 1987-10-15 1989-08-29 Oratech Pharmaceutical Development Corporation Liquid ibuprofen compositions and methods of making them
US4868214A (en) * 1987-11-17 1989-09-19 Analgesic Associates Onset-hastened/enhanced analgesia
US4835188A (en) * 1987-12-08 1989-05-30 American Home Products Corporation Spray dried ibuprofen
US4996209A (en) * 1988-06-20 1991-02-26 Alcon Laboratories, Inc. Ophthalmic antiinflammatory compositions comprising S(+)-flurbiprofen
DE3824353A1 (en) * 1988-07-19 1990-01-25 Paz Arzneimittelentwicklung METHOD FOR SEPARATING MIXED ENANTIOMER ARYLPROPIONIC ACIDS
DK546289D0 (en) * 1989-11-02 1989-11-02 Danochemo As carotenoid
DE4028906A1 (en) * 1990-09-12 1992-03-19 Paz Arzneimittelentwicklung MEDICINAL PRODUCTS AND THEIR PREPARATION AND THEIR USE IN THE CONTROL OF PAIN AND / OR DEFENSE AND / OR FEVER OF ANIMALS AND PEOPLE

Also Published As

Publication number Publication date
DE4140172C2 (en) 1995-12-21
EP0615439B1 (en) 1995-11-08
ES2082523T3 (en) 1996-03-16
WO1993010760A1 (en) 1993-06-10
DE59204281D1 (en) 1995-12-14
DE4140172A1 (en) 1993-06-17
EP0615439A1 (en) 1994-09-21
ATE129891T1 (en) 1995-11-15
AU3080092A (en) 1993-06-28
GR3018931T3 (en) 1996-05-31

Similar Documents

Publication Publication Date Title
MX9600857A (en) Multiple unit tableted dosage form i.
AU1534699A (en) Osmotic dosage form comprising first and second coats
EP0513702A3 (en) Melatonin derivaties for use in the therapy of sleep disorders and in pre-anaesthetic medication
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
MX9604354A (en) New oral pharmaceutical dosage form.
ES2180251T3 (en) COMPRESSED COVERED WITH POLYMER, CONTAINING AMOXYCLINE AND CLAVULANATE.
TR199801180T2 (en) New compounds with analgesic effect.
ATE200981T1 (en) MEDICINAL PREPARATION CONTAINING AMOXYCILLIN AND POTASSIUM CLAVUNALATE
ES2183841T3 (en) DOSAGE FORMS TO ADMINISTER A FARMASCO IN A LQUIDID FORMULATION.
ES2090712T3 (en) ACUTE MEDICINE CONTAINING IBUPROPHEN AND ITS USE.
RS50298B (en) Directly compressibile matrix for controlled release of single daily doses of clarithromycin
AP1901A (en) Pharmaceutical composition for modified release insulin sensitiser.
LTIP1731A (en) Substituted 4-phenyl-4-piperidinecarboxamides with both local anaesthetic and analgesic effect as well as processes for their preparation
DK0615443T3 (en) Medicinal product in acutely active form containing Flurbiprofen and its use
DK0615439T3 (en) Iburprofen-containing retard drug and its use
ATE38151T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING STABLE 5-ADENOSYL-L-METHIONINE SALTS FOR ORAL USE.
DK0615447T3 (en) Flurbiprofen-containing retard drug and its use
ATE124627T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING DICLOFENAC SODIUM FOR TOPICAL USE.
PT97052A (en) METHOD FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS CONTAINING BAMBUTEROL, SUITABLE FOR DECREASING THE CONTENT OF BLOOD LIPIDS
MX9302986A (en) MEDICINES CONTAINING METRIFONATE AND PROCEDURE FOR ITS PREPARATION
AP9200405A0 (en) Pharmaceutical formulations comprised of micronised halofantrine.
JO1880B1 (en) Multiple Unit Tableted Dosage Form I
DK0615446T3 (en) Retard drug containing a nanosol dihydropyridine derivative and its preparation